ALAbdullah Lodhi

Abdullah Lodhi

*This is an algorithmically generated author record based on publicly available information.

Abdullah Lodhi has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diabetic Ketoacidosis Unveiling Severe Hypertriglyceridemia and Acute Mild Pancreatitis: A Rare Initial Manifestation of Type 2 Diabetes Mellitus

    by Parth Adrejiya, Sunil Shahi, Abdullah Lodhi, Mohammad Abubaker, Jill Vora, Gurkeerat Singh, Cyril Anara, Swathi Gorle, Ashok Kanugula

    BACKGROUND Diabetic ketoacidosis (DKA) in combination with hypertriglyceridemia-induced acute mild pancreatitis is a rare but life-threatening clinical triad that occurs in a small subset of patients with DKA. It is an exceptionally uncommon initial presentation of type 2 diabetes mellitus in adults. This case highlights the importance of early recognition and multidisciplinary intervention in such complex clinical scenarios. CASE REPORT A 35-year-old man with no known history of diabetes mellitus presented with 3 days of epigastric abdominal pain. Initial laboratory tests confirmed DKA and severe hypertriglyceridemia (triglycerides 2464 mg/dL), with no lipase elevation and no evidence of gallstones or alcohol-related pancreatitis. The patient was treated with intravenous fluids, insulin infusion, and electrolyte replacement under a DKA protocol. He was placed on a fasting regimen (nil per os) and was monitored with serial metabolic panels and lipid assessments. DKA resolved, and triglyceride levels normalized with insulin therapy alone. He was subsequently transitioned to subcutaneous insulin; atorvastatin and fenofibrate were initiated for long-term lipid control. Upon clinical stabilization, he was discharged with diabetic supplies, dietary education, and outpatient endocrinology follow-up. CONCLUSIONS This case underscores a rare initial manifestation of type 2 diabetes as DKA complicated by hypertriglyceridemia-induced mild pancreatitis. Prompt diagnosis and protocol-based management can substantially improve outcomes in such patients. Increased clinician awareness is essential to optimize care in similar cases.

  • Open Access

    Physician Transfer Versus Patient Transfer for Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis

    by Adnan I. Qureshi, Abdullah Lodhi, Hamza Maqsood, Xiaoyu Ma, Gordian J. Hubert, Camilo R. Gomez, Chun S. Kwok, Daniel E. Ford, Daniel F. Hanley, David R. Mehr, et al.

    Background: Physician transfer is an alternate option to patient transfer for expedient performance of mechanical thrombectomy in patients with acute ischemic stroke. Methods and Results: We conducted a systematic review to identify studies that evaluate the effect of physician transfer in patients with acute ischemic stroke who undergo mechanical thrombectomy. A search of PubMed, Scopus, and Web of Science was undertaken, and data were extracted. A statistical pooling with random‐effects meta‐analysis was performed to examine the odds of reduced time interval between stroke onset and recanalization, functional independence, death, and angiographic recanalization. A total of 12 studies (11 nonrandomized observational studies and 1 nonrandomized controlled trial) were included, with a total of 1894 patients. Physician transfer was associated with a significantly shorter time interval between stroke onset and recanalization with a pooled mean difference estimate of −62.08 (95% CI, −112.56 to −11.61]; P =0.016; 8 studies involving 1419 patients) with high between‐study heterogeneity in the estimates ( I 2 =90.6%). The odds for functional independence at 90 days were significantly higher (odds ratio, 1.29 [95% CI, 1.00–1.66]; P =0.046; 7 studies with 1222 patients) with physician transfer with low between‐study heterogeneity ( I 2 =0%). Physician transfer was not associated with higher odds of near‐complete or complete angiographic recanalization (odds ratio, 1.18 [95% CI, 0.89–1.57; P =0.25; I 2 =2.8%; 11 studies with 1856 subjects). Conclusions: Physician transfer was associated with a significant reduction in the mean of time interval between symptom onset and recanalization and increased odds for functional independence at 90 days with physician transfer compared with patient transfer among patients who undergo mechanical thrombectomy.


  • Impact of post-procedure stenosis on outcomes of patients with severe intracranial stenosis treated with intracranial stent placement

    by Ravi S Nunna, Xiaoyu Ma, Sabrina Genovese, Abdullah Lodhi, Navpreet K Bains, David Cohen, Caitlyn Smith, Michael J Ortiz, Farhan Siddiq, Camilo R Gomez, et al.

    Background The optimal target post-procedure stenosis after percutaneous angioplasty and stent placement (PTAS) for intracranial stenosis is unknown. We determined the effect of post-procedure stenosis after intracranial PTAS on subsequent clinical events in patients with severe symptomatic intracranial stenosis. Methods We categorized the severity of post-procedure stenosis as ‘Results The severity of post-procedure stenosis was categorized as Conclusion In the absence of any benefit on short- and long-term outcomes, strategies to achieve a low severity of post-procedure stenosis among patients with severe intracranial stenosis may not be warranted.


  • Self‐expanding versus balloon expandable stent for intracranial arterial stenosis: A systematic review and meta‐analysis

    by Adnan I. Qureshi, Abdullah Lodhi, Xiaoyu Ma, Rehan Ahmed, Chun Shing Kwok, Hamza Maqsood, Jahanzeb Liaqat, Ameer E. Hassan, Farhan Siddiq, Camilo R. Gomez, et al.

    Background and Purpose: There are limited data regarding the comparison of balloon expandable stents (BES) and self‐expanding stents (SES) for the treatment of intracranial arterial stenosis.Methods: We conducted a systematic review to identify studies that compared SES and BES in patients with symptomatic intracranial arterial stenosis. Data were extracted from relevant studies found through a search of PubMed, Scopus, and Web of Science until from January 1, 2010 to September 28, 2023. Statistical pooling with random‐effects meta‐analysis was undertaken to compare the rates/severity of postprocedure stenosis, technical success, 30‐day stroke and/or death, cumulative clinical endpoints, and restenosis rates.Results: A total of 20 studies were included. The standardized mean difference (SMD) for postprocedure stenosis (%) was significantly lower (SMD: −0.52, 95% confidence interval [CI]: −0.79 to −0.24, p < .001, 10 studies involving 1515 patients) with BES. The odds for 30‐day stroke and/or death were significantly lower (odds ratio [OR] 0.68, 95% CI: 0.50‐0.94, p = .019, 15 studies involving 2431 patients), and cumulative clinical endpoints on follow‐up were nonsignificantly lower (OR 0.64, 95% CI: 0.30‐1.37, p = .250, 10 studies involving 947 patients) with BES. The odds for restenosis during follow‐up were significantly lower (OR 0.50, 95% CI: 0.31‐0.80, p = .004, 13 studies involving 1115 patients) with BES.Conclusions: Compared with SES, BES were associated with lower rates of postprocedure 30‐day stroke and/or death with lower rates of restenosis during follow up and the treatment of symptomatic intracranial arterial stenosis.


  • Mechanical thrombectomy with intra-arterial thrombolysis versus mechanical thrombectomy alone in patients with acute ischemic stroke: A systematic review and meta-analysis

    by Adnan I Qureshi, Abdullah Lodhi, Iqra N Akhtar, Xiaoyu Ma, Danish Kherani, Chun Shing Kwok, Daniel E Ford, Daniel F Hanley, Ameer E Hassan, Thanh N Nguyen, et al.

    Background: There is conflicting evidence as to whether intra-arterial thrombolysis (IAT) adds benefit in patients with acute stroke who undergo mechanical thrombectomy (MT). Methods: We conducted a systematic review to identify studies that evaluate IAT in patients with acute stroke who undergo MT. Data were extracted from relevant studies found through a search of PubMed, Scopus, and Web of Science until February 2023. Statistical pooling with random effects meta-analysis was undertaken to evaluate odds of functional independence, mortality, and near-complete or complete angiographic recanalization with IAT compared to no IAT. Results: A total of 18 studies were included (3 matched, 14 unmatched, and 1 randomized). The odds ratio (OR) for functional independence (modified Rankin Scale: 0–2) at 90 days was 1.14 (95% confidence interval (CI): 0.95–1.37, p = 0.17, 16 studies involving 7572 patients) with IAT with moderate between-study heterogeneity (I2 = 38.1%). The OR for functional independence with IAT was 1.28 (95% CI: 0.92–1.78, p = 0.15) in studies that were either matched or randomized and 1.24 (95% CI: 0.97–1.58, p = 0.08) in studies with the highest quality score. IAT was associated with higher odds of near-complete or complete angiographic recanalization (OR: 1.65, 95% CI: 1.03–2.65, p = 0.04) in studies that were either matched or of randomized comparisons. Conclusion: Although the odds of functional independence appeared to be higher with IAT and MT compared with MT alone, none of the results were statistically significant. A prominent effect of the design and quality of the studies was observed on the association between IAT and functional independence at 90 days.


  • Effect of Radiographic Contrast Media Shortage on Stroke Evaluation in the United States

    by A.I. Qureshi, A. Grintal, A.C. DeGaetano, M. Goren, A. Lodhi, D. Golan, A.E. Hassan

    BACKGROUND AND PURPOSE: We performed this study to identify the effect of the nationwide iodinated contrast media shortage due to reduction in GE Healthcare production, initiated on April 19, 2022, on the evaluation of patients with stroke. MATERIALS AND METHODS: We analyzed the data on 72,514 patients who underwent imaging processed with commercial software in a sample of 399 hospitals in United States from February 28, 2022, through July 10, 2022. We quantified the percentage change in the daily number of CTAs and CTPs performed before and after April 19, 2022. RESULTS: The daily counts of individual patients who underwent CTAs decreased (a 9.6% reduction, P = .002) from 1.584 studies per day per hospital to 1.433 studies per day per hospital. The daily counts of individual patients who underwent CTPs decreased (a 25.9% reduction, P = .003) from 0.484 studies per day per hospital to 0.358 studies per day per hospital. A significant reduction in CTPs using GE Healthcare contrast media (43.06%, P < .001) was seen but not in CTPs using non-GE Healthcare contrast media (increase by 2.93%, P = .29). The daily counts of individual patients with large-vessel occlusion decreased (a 7.69% reduction) from 0.124 per day per hospital to 0.114 per day per hospital. CONCLUSIONS: Our analysis reported changes in the use of CTA and CTP in patients with acute ischemic stroke during the contrast media shortage. Further research needs to identify effective strategies to reduce the reliance on contrast media–based studies such as CTA and CTP without compromising patient outcomes.


  • Intraarterial thrombolytics as an adjunct to mechanical thrombectomy in patients with basilar artery occlusion

    by Adnan I. Qureshi, Abdullah Lodhi, Xiaoyu Ma, Chunrong Tao, Rui Li, Pengfei Xu, Wei Hu, for Endovascular Treatment for Acute Basilar Artery Occlusion (ATTENTION) Registry Investigators

    Background and Purpose: There are limited data regarding safety and effectiveness of concurrent intraarterial thrombolytics as adjunct to mechanical thrombectomy in acute ischemic stroke patients with basilar artery occlusion.Methods: We analyzed data from a prospective multicenter registry to assess the independent effect of intraarterial thrombolysis on (1) favorable outcome (modified Rankin Scale 0‐3) at 90 days; (2) symptomatic intracranial hemorrhage (sICH) within 72 hours; and (3) death within 90 days post‐enrollment after adjustment for potential confounders.Results: There was no difference in the adjusted odds of achieving favorable outcome at 90 days (odds ratio [OR] = 1.1, 95% confidence interval [CI]: 0.73‐1.68) in patients who received intraarterial thrombolysis (n = 126) compared with those who did not receive intraarterial thrombolysis (n = 1546) despite significantly higher use in patients with postprocedure modified Thrombolysis in Cerebral Infarction (mTICI) grade <3. There were no differences in adjusted odds of sICH within 72 hours (OR = 0.8, 95% CI: 0.31‐2.08) or death within 90 days (OR = 0.91, 95% CI: 0.60‐1.37). In subgroup analyses, intraarterial thrombolysis was associated with (nonsignificantly) higher odds of achieving a favorable outcome at 90 days among patients aged between 65 and 80 years, those with National Institutes of Health Stroke Scale score <10, and those with postprocedure mTICI grade 2b.Conclusions: Our analysis supported the safety of intraarterial thrombolysis as adjunct to mechanical thrombectomy in acute ischemic stroke patients with basilar artery occlusion. Identification of patient subgroups in whom intraarterial thrombolytics appeared to be more beneficial may assist in future clinical trial designs.